» Articles » PMID: 24392351

The Role of Syndecan-1 in Cellular Signaling and Its Effects on Heparan Sulfate Biosynthesis in Mesenchymal Tumors

Overview
Journal Front Oncol
Specialty Oncology
Date 2014 Jan 7
PMID 24392351
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Proteoglycans (PGs) and in particular the syndecans are involved in the differentiation process across the epithelial-mesenchymal axis, principally through their ability to bind growth factors and modulate their downstream signaling. Malignant tumors have individual proteoglycan profiles, which are closely associated with their differentiation and biological behavior, mesenchymal tumors showing a different profile from that of epithelial tumors. Syndecan-1 is the main syndecan of epithelial malignancies, whereas in sarcomas its expression level is generally low, in accordance with their mesenchymal phenotype and highly malignant behavior. This proteoglycan is often overexpressed in adenocarcinoma cells, whereas mesothelioma and fibrosarcoma cells express syndecan-2 and syndecan-4 more abundantly. Increased expression of syndecan-1 in mesenchymal tumors changes the tumor cell morphology to an epithelioid direction whereas downregulation results in a change in shape from polygonal to spindle-like morphology. Although syndecan-1 plays major roles on the cell-surface, there are also intracellular functions, which are not very well studied. On the functional level, syndecan-1 affects mesenchymal tumor cell proliferation, adhesion, migration and motility, and the effect varies with the different domains of the core protein. Syndecan-1 may exert stimulatory or inhibitory effects, depending on the concentration of various mitogens, enzymes, and signaling molecules, the ratio between the shed and membrane-associated syndecan-1 and histological grade of the tumour. Growth factor signaling seems to be delicately controlled by regulatory loops involving the syndecan expression levels and their sulfation patterns. Overexpression of syndecan-1 modulates the biosynthesis and sulfation of heparan sulfate and it also affects the expression of other PGs. On transcriptomic level, syndecan-1 modulation results in profound effects on genes involved in regulation of cell growth.

Citing Articles

Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma.

Files R, Cardoso C, Prada J, Silva F, Pires I Vet Sci. 2024; 11(12).

PMID: 39728992 PMC: 11680152. DOI: 10.3390/vetsci11120652.


Syndecan-1 Levels in Females with Active Rheumatoid Arthritis.

Rodriguez-Jimenez N, Gonzalez-Ponce F, Gamez-Nava J, Ramirez-Villafana M, Saldana-Cruz A, Ponce-Guarneros J J Clin Med. 2024; 13(14).

PMID: 39064151 PMC: 11278313. DOI: 10.3390/jcm13144110.


Tigilanol Tiglate-Induced Changes in Secretome Profiles Alter C-Met Phosphorylation and Cell Surface Protein Expression in H357 Head and Neck Cancer Cells.

Antwi F, Awad T, Larin M, Heesom K, Lewis P, Reddell P Cells. 2024; 13(11.

PMID: 38891113 PMC: 11171882. DOI: 10.3390/cells13110982.


KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.

Shen K, Chen B, Yang L, Gao W Int J Genomics. 2023; 2023:4662480.

PMID: 37954130 PMC: 10635752. DOI: 10.1155/2023/4662480.


Syndecan-1: From a Promising Novel Cardiac Biomarker to a Surrogate Early Predictor of Kidney and Liver Injury in Patients with Acute Heart Failure.

Miftode R, Costache I, Constantinescu D, Mitu O, Timpau A, Hancianu M Life (Basel). 2023; 13(4).

PMID: 37109427 PMC: 10146167. DOI: 10.3390/life13040898.


References
1.
Ridley R, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson R . Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood. 1993; 81(3):767-74. View

2.
Wittrup A, Zhang S, Ten Dam G, van Kuppevelt T, Bengtson P, Johansson M . ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican. J Biol Chem. 2009; 284(47):32959-67. PMC: 2781711. DOI: 10.1074/jbc.M109.036129. View

3.
Seidel C, Borset M, Hjertner O, Cao D, Abildgaard N, Hjorth-Hansen H . High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood. 2000; 96(9):3139-46. View

4.
Zong F, Fthenou E, Wolmer N, Hollosi P, Kovalszky I, Szilak L . Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. PLoS One. 2009; 4(10):e7346. PMC: 2750749. DOI: 10.1371/journal.pone.0007346. View

5.
Dias R, Shibata S, Hashimoto-Uoshima M, Podyma-Inoue K, Ishikawa I, Yanagishita M . Syndecan-1 expression during the formation of junctional epithelium. J Periodontol. 2005; 76(5):696-704. DOI: 10.1902/jop.2005.76.5.696. View